PRESS RELEASE published on 03/21/2023 at 11:00, 1 year 8 months ago Karbon-X Corp Signs Letter of Intent with Resolute Resources Ltd to Offset all CO2 Emissions Associated with Resolute's Inaugural Exploration Program at Grimshaw and to Explore Procedures and Processes Leading To Top Tier Environmental Metrics
PRESS RELEASE published on 03/01/2023 at 03:21, 1 year 8 months ago Karbon-X Corp Announces Launch of the Karbon-X Web-App: Providing a Platform for People To Easily Offset a Portion of Their Carbon Footprint
PRESS RELEASE published on 01/23/2023 at 20:20, 1 year 9 months ago KARBON-X CORP Retained by Power Nickel Inc to Offset their 2023 Drill Program of Up to 40,000 metres, with Voluntary Carbon Offsets
Published on 11/21/2024 at 14:00, 13 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 13 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 13 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 43 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 37 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 58 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 15 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 53 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 28 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 28 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
